Scientific article

Antalgie chez les patients avec une atteinte hépatique

Published inRevue médicale suisse, vol. 11, no. 480, p. 1380-1384
Publication date2015

The lack of clear recommendations makes optimal pain management difficult in patients with hepatic function impairment. This article reviews the evidence on commonly used analgesics (paracetamol, NSAIDs, opiates). Paracetamol can be safely used at low doses (2-3 grams per day) for a period not exceeding a few days. NSAIDs should be avoided because of their direct hepatic toxicity and an increased risk of life-threatening side-effects (hemorrhagic, renal). Glucuronoconjugated opiates should be preferred but all must be used carefully because of the risk of side effects. Dosage reduction and/or increased dose interval are often required.

  • Acetaminophen/therapeutic use
  • Analgesia/adverse effects/methods
  • Analgesics/administration & dosage/adverse effects
  • Analgesics, Opioid/therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
  • Humans
  • Liver Diseases/complications/metabolism
  • Pain/complications/drug therapy/metabolism
  • Pain Management/adverse effects/methods
Citation (ISO format)
INNAURATO, Giovanni, PIGUET, Valérie, SIMONET, Martine Louis. Antalgie chez les patients avec une atteinte hépatique. In: Revue médicale suisse, 2015, vol. 11, n° 480, p. 1380–1384.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation08/24/2016 1:48:00 PM
First validation08/24/2016 1:48:00 PM
Update time03/15/2023 12:39:37 AM
Status update03/15/2023 12:39:36 AM
Last indexation10/19/2023 1:51:01 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack